• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1,4-二取代-1,2,3-三唑衍生物对基孔肯雅病毒的抗病毒活性评估

Antiviral evaluation of 1,4-disubstituted-1,2,3-triazole derivatives against Chikungunya virus.

作者信息

Rabelo Vitor Won-Held, da Silva Verônica Diniz, Sanchez Nuñez Maria Leonisa, Dos Santos Corrêa Amorim Leonardo, Buarque Camilla Djenne, Kuhn Richard J, Abreu Paula Alvarez, Nunes de Palmer Paixão Izabel Christina

机构信息

Programa de Pós-graduação em Ciências e Biotecnologia, Instituto de Biologia, Universidade Federal Fluminense, Niterói, RJ, CEP, 24210-201, Brazil.

Laboratório de Síntese Orgânica, Pontifícia Universidade Católica do Rio de Janeiro, Rio de Janeiro, RJ, CEP, 22451-900, Brazil.

出版信息

Future Virol. 2023 Sep;18(13):865-880. doi: 10.2217/fvl-2023-0142. Epub 2023 Oct 25.

DOI:10.2217/fvl-2023-0142
PMID:37974899
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10636642/
Abstract

AIM

This work aimed to investigate the antiviral activity of two 1,4-disubstituted-1,2,3-triazole derivatives ( and ) against Chikungunya virus (CHIKV) replication.

MATERIALS & METHODS: Cytotoxicity was analyzed using colorimetric assays and the antiviral potential was evaluated using plaque assays and computational tools.

RESULTS

Compound 2 showed antiviral activity against CHIKV 181-25 in BHK-21 and Vero cells. Also, this compound presented a higher activity against CHIKV BRA/RJ/18 in Vero cells, like compound 1. Compound 2 exhibited virucidal activity and inhibited virus entry while compound 1 inhibited virus release. Molecular docking suggested that these derivatives inhibit nsP1 protein while compound 1 may also target capsid protein.

CONCLUSION

Both compounds exhibit promising antiviral activity against CHIKV by blocking different steps of virus replication.

摘要

目的

本研究旨在探究两种1,4 - 二取代 - 1,2,3 - 三唑衍生物(和)对基孔肯雅病毒(CHIKV)复制的抗病毒活性。

材料与方法

使用比色法分析细胞毒性,并使用蚀斑试验和计算工具评估抗病毒潜力。

结果

化合物2在BHK - 21和Vero细胞中对CHIKV 181 - 25显示出抗病毒活性。此外,与化合物1一样,该化合物在Vero细胞中对CHIKV BRA/RJ/18表现出更高的活性。化合物2表现出杀病毒活性并抑制病毒进入,而化合物1抑制病毒释放。分子对接表明这些衍生物抑制nsP1蛋白,而化合物1也可能靶向衣壳蛋白。

结论

两种化合物均通过阻断病毒复制的不同步骤,对CHIKV表现出有前景的抗病毒活性。

相似文献

1
Antiviral evaluation of 1,4-disubstituted-1,2,3-triazole derivatives against Chikungunya virus.1,4-二取代-1,2,3-三唑衍生物对基孔肯雅病毒的抗病毒活性评估
Future Virol. 2023 Sep;18(13):865-880. doi: 10.2217/fvl-2023-0142. Epub 2023 Oct 25.
2
Imidazonaphthyridine effects on Chikungunya virus replication: Antiviral activity by dependent and independent of interferon type 1 pathways.咪唑并[1,2-a]吡啶并[2,3-d]嘧啶对基孔肯雅病毒复制的影响:干扰素 1 型途径依赖性和非依赖性的抗病毒活性。
Virus Res. 2023 Jan 15;324:199029. doi: 10.1016/j.virusres.2022.199029. Epub 2022 Dec 22.
3
Explorations on the antiviral potential of zinc and magnesium salts against chikungunya virus: implications for therapeutics.锌盐和镁盐抗基孔肯雅病毒的抗病毒潜力研究:治疗意义。
Front Cell Infect Microbiol. 2024 Jun 4;14:1335189. doi: 10.3389/fcimb.2024.1335189. eCollection 2024.
4
In silico and in vitro evaluation of silibinin: a promising anti-Chikungunya agent.水飞蓟宾的计算机模拟和体外评估:一种有前景的抗基孔肯雅病毒药物。
In Vitro Cell Dev Biol Anim. 2022 Mar;58(3):255-267. doi: 10.1007/s11626-022-00666-x. Epub 2022 Apr 5.
5
Exploring the antiviral activities of the FDA-approved drug sulfadoxine and its derivatives against Chikungunya virus.探索已获 FDA 批准的药物磺胺多辛及其衍生物对基孔肯雅病毒的抗病毒活性。
Pharmacol Rep. 2024 Oct;76(5):1147-1159. doi: 10.1007/s43440-024-00635-z. Epub 2024 Aug 16.
6
Identification of small molecule inhibitors of the Chikungunya virus nsP1 RNA capping enzyme.鉴定基孔肯雅病毒 nsP1 RNA 加帽酶的小分子抑制剂。
Antiviral Res. 2018 Jun;154:124-131. doi: 10.1016/j.antiviral.2018.03.013. Epub 2018 Apr 20.
7
Vathasura Kudineer, an Andrographis based polyherbal formulation exhibits immunomodulation and inhibits chikungunya virus (CHIKV) under invitro conditions.瓦塔苏鲁库迪尼尔,一种基于穿心莲的复方草药制剂,表现出免疫调节作用,并在体外条件下抑制基孔肯雅病毒(CHIKV)。
J Ethnopharmacol. 2023 Feb 10;302(Pt A):115762. doi: 10.1016/j.jep.2022.115762. Epub 2022 Sep 29.
8
Organometallic Complex Strongly Impairs Chikungunya Virus Entry to the Host Cells.有机金属络合物严重损害基孔肯雅病毒进入宿主细胞。
Front Microbiol. 2020 Dec 15;11:608924. doi: 10.3389/fmicb.2020.608924. eCollection 2020.
9
6'-β-Fluoro-Homoaristeromycin and 6'-Fluoro-Homoneplanocin A Are Potent Inhibitors of Chikungunya Virus Replication through Their Direct Effect on Viral Nonstructural Protein 1.6'-β-氟霍巴他汀和 6'-氟霍巴他霉素是通过直接作用于病毒非结构蛋白 1 而对基孔肯雅病毒复制具有强大抑制作用的药物。
Antimicrob Agents Chemother. 2020 Mar 24;64(4). doi: 10.1128/AAC.02532-19.
10
In vitro and in vivo studies reveal α-Mangostin, a xanthonoid from Garcinia mangostana, as a promising natural antiviral compound against chikungunya virus.体外和体内研究表明,来自藤黄科藤黄属植物的一种紫檀芪,α-倒捻子素,是一种有前途的抗基孔肯雅病毒的天然抗病毒化合物。
Virol J. 2021 Feb 28;18(1):47. doi: 10.1186/s12985-021-01517-z.

引用本文的文献

1
In Silico Drug Repurposing Uncovered the Antiviral Potential of the Antiparasitic Drug Oxibendazole Against the Chikungunya Virus.计算机辅助药物重新利用揭示了抗寄生虫药物奥昔苯达唑对基孔肯雅病毒的抗病毒潜力。
ACS Omega. 2024 Jun 13;9(25):27632-27642. doi: 10.1021/acsomega.4c03417. eCollection 2024 Jun 25.

本文引用的文献

1
Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial.一种单次接种的减毒活寨卡病毒疫苗的安全性和免疫原性:一项双盲、多中心、随机、安慰剂对照、3 期临床试验。
Lancet. 2023 Jun 24;401(10394):2138-2147. doi: 10.1016/S0140-6736(23)00641-4. Epub 2023 Jun 12.
2
Structural insights into the inhibition of the nsP2 protease from Chikungunya virus by molecular modeling approaches.通过分子建模方法研究基孔肯雅病毒 nsP2 蛋白酶抑制的结构见解。
J Mol Model. 2022 Sep 12;28(10):311. doi: 10.1007/s00894-022-05316-3.
3
A Review on Chikungunya Virus Epidemiology, Pathogenesis and Current Vaccine Development.基孔肯雅热病毒的流行病学、发病机制和当前疫苗开发研究进展综述。
Viruses. 2022 May 5;14(5):969. doi: 10.3390/v14050969.
4
Selective Estrogen Receptor Modulators Limit Alphavirus Infection by Targeting the Viral Capping Enzyme nsP1.选择性雌激素受体调节剂通过靶向病毒帽状结构酶 nsP1 限制甲病毒感染。
Antimicrob Agents Chemother. 2022 Mar 15;66(3):e0194321. doi: 10.1128/AAC.01943-21. Epub 2022 Jan 18.
5
Emerging and Re-emerging Vector-Borne Infectious Diseases and the Challenges for Control: A Review.新出现和再次出现的媒介传播传染病及其控制面临的挑战:综述
Front Public Health. 2021 Oct 5;9:715759. doi: 10.3389/fpubh.2021.715759. eCollection 2021.
6
Recent Advances in In Silico Target Fishing.计算机辅助药物靶点发现的最新进展
Molecules. 2021 Aug 24;26(17):5124. doi: 10.3390/molecules26175124.
7
The global emergence of Chikungunya infection: An integrated view.基孔肯雅热感染的全球出现:综合观点。
Rev Med Virol. 2022 May;32(3):e2287. doi: 10.1002/rmv.2287. Epub 2021 Aug 24.
8
In Vitro Inhibition of Alphaviruses by Lycorine.石蒜堿对甲病毒的体外抑制作用。
Virol Sin. 2021 Dec;36(6):1465-1474. doi: 10.1007/s12250-021-00438-z. Epub 2021 Aug 10.
9
Antivirals against the Chikungunya Virus.抗基孔肯雅病毒药物。
Viruses. 2021 Jul 5;13(7):1307. doi: 10.3390/v13071307.
10
New Insights into Chikungunya Virus Infection and Pathogenesis.基孔肯雅热病毒感染与发病机制的新认识。
Annu Rev Virol. 2021 Sep 29;8(1):327-347. doi: 10.1146/annurev-virology-091919-102021. Epub 2021 Jul 13.